Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 1 of 15
Akamis Bio
IP Group (Evergreen)
UKSector
Biotech
InvestorIP Group
Entry
2015
Hold
11yr
Owners
2
Memo Therapeutics
Ysios BioFund III
CHSector
Biotech
InvestorYsios Capital Partners
Entry
2018
Hold
8yr
Owners
2
Exit
2026
Dark Blue Therapeutics
Oxford Science Enterprises Balance Sheet
UKSector
Biotech
InvestorOxford Science Enterprises
Entry
2020
Hold
6yr
Exit
2026
Soleno Therapeutics
Abingworth Bioventures VI
USSector
Biotech
InvestorAbingworth
Entry
2018
Hold
8yr
Exit
2026
Chain Biotechnology
UK Innovation and Science Seed Fund
UKSector
Biotech
InvestorFuture Planet Capital
Entry
2017
Hold
9yr
Exit
2026
Pantherna Therapeutics
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2019
Hold
7yr
Exit
2026
Congenica
Parkwalk Opportunities EIS Fund
UKSector
Biotech
InvestorParkwalk Advisors
Entry
2014
Hold
11yr
Owners
3
Exit
2025
Araris Biotech
4BIO Ventures II
SwitzerlandSector
Biotech
Investor4Bio Partners
Entry
2020
Hold
5yr
Exit
2025
Believer Meats
Cibus Fund II
Israel
Sector
Biotech
InvestorCibus Capital
Entry
2021
Hold
4yr
Exit
2025
Biocrates
MIG Fonds 16
AustriaSector
Biotech
InvestorMIG Capital
Entry
2019
Hold
6yr
Exit
2025
CureVac
dievini Hopp BioTech holding (Evergreen Balance Sheet)
GermanySector
Biotech
Investordievini Hopp BioTech holding
Entry
2005
Hold
20yr
Exit
2025
Evergreen Theragnostics
LIFTT
United StatesSector
Biotech
InvestorLIFTT
Entry
2024
Hold
1yr
Exit
2025
Officinae Bio
Nucleus Capital I
ItalySector
Biotech
InvestorNucleus Capital
Entry
2021
Hold
4yr
Exit
2025
Scorpion Therapeutics
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
5yr
Exit
2025
Dorian Therapeutics
Vento Fund I
United StatesSector
Biotech
InvestorVento
Entry
2023
Hold
2yr
Exit
2025
EsoBiotec
Invivo Ventures
BelgiumSector
Biotech
InvestorInvivo Partners
Entry
2023
Hold
2yr
Exit
2025
GQ Bio Therapeutics
Innovationsstarter Fonds Hamburg I
GermanySector
Biotech
InvestorIFB Innovationsstarter
Entry
2012
Hold
13yr
Exit
2025
Boundless Bio
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2023
Hold
1yr
Exit
2024
Dynamic Biosensors
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2012
Hold
12yr
Owners
3
Exit
2024
AptaTargets
Inveready Biotech II
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2017
Hold
7yr
Exit
2024
BioData (Labguru)
Holtzbrinck Digital Balance Sheet
Israel
Sector
Biotech
InvestorHoltzbrinck Digital
Entry
2010
Hold
14yr
Exit
2024
CARDIOR
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
7yr
Exit
2024
Cardior Pharmaceuticals
coparion
GermanySector
Biotech
Investorcoparion
Entry
2021
Hold
3yr
Exit
2024
Cytox Group
UK Innovation and Science Seed Fund
UKSector
Biotech
InvestorFuture Planet Capital
Entry
–
Exit
2024
FairJourney Biologics
GHO Capital Fund II LP
PortugalSector
Biotech
InvestorGHO Capital
Entry
2020
Hold
4yr
Exit
2024
Metagenomi
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
4yr
Exit
2024
Morphosys
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
1996
Hold
28yr
Exit
2024
Q32 Bio
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
4yr
Exit
2024
ReNeuron Group
Obotritia Capital KGaA
United KingdomSector
Biotech
InvestorObotritia Capital
Entry
–
Exit
2024
SensID GmbH
Venture Capital Fonds MV GmbH
GermanySector
Biotech
InvestorGENIUS Venture Capital
Entry
2018
Hold
6yr
Exit
2024
PetMedix
CIC Fund II
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2019
Hold
4yr
Owners
2
Exit
2023
Sense Biodetection
CIC Fund I
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2016
Hold
7yr
Owners
2
Synthelis
CASRA Capital
FranceSector
Biotech
InvestorCrédit Agricole Alpes Développement
Entry
2013
Hold
10yr
Exit
2023
Emergence Therapeutics
Gruenderfonds Ruhr I
GermanySector
Biotech
InvestorGruenderfonds Ruhr
Entry
2019
Hold
4yr
Owners
3
Exit
2023
adivo
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2018
Hold
5yr
Exit
2023
BianoGMP GmbH
Thueringer Startup-Fonds (TSF)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2018
Hold
5yr
Exit
2023
Calixar
Capital 2
FranceSector
Biotech
InvestorXAnge
Entry
2012
Hold
11yr
Exit
2023
Caraway Therapeutics
Dementia Discovery Fund
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2017
Hold
6yr
Exit
2023
Carisma Therapeutics
Wellington Partners Life Sciences
United StatesSector
Biotech
InvestorWellington Partners
Entry
2018
Hold
5yr
Exit
2023
Diatech
Alto Capital IV
ItalySector
Biotech
InvestorAlto Partners SGR
Entry
2021
Hold
2yr
Exit
2023
EryDel
Innogest Capital I
ItalySector
Biotech
InvestorOrigine SGR
Entry
2008
Hold
15yr
Exit
2023
Oculis
Earlybird Health
SwitzerlandSector
Biotech
InvestorEarlybird Venture Capital
Entry
2020
Hold
3yr
Exit
2023
T3 Pharmaceuticals
Boehringer Ingelheim Venture Fund
SwitzerlandSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2019
Hold
4yr
Exit
2023
Zihpp
IP Group (Evergreen)
UKSector
Biotech
InvestorIP Group
Entry
2019
Hold
4yr
Exit
2023
c-LEcta
SHS III
GermanySector
Biotech
InvestorSHS Gesellschaft für Beteiligungsmanagement
Entry
2006
Hold
16yr
Owners
2
Exit
2022
DJS Antibodies
LifeArc Ventures
UKSector
Biotech
InvestorLifeArc
Entry
2016
Hold
6yr
Owners
2
Exit
2022
Algenex
Columbus Innvierte Life Science Fund I
SpainSector
Biotech
InvestorColumbus Venture Partners
Entry
2017
Hold
5yr
Exit
2022
Belyntic
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2019
Hold
3yr
Exit
2022
c-LEcta GmbH
MFT Mittelstands-Fonds Thueringen (MFT)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2018
Hold
4yr
Exit
2022
CEVEC Pharmaceuticals
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2009
Hold
13yr
Exit
2022